Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-093619
Filing Date
2023-08-18
Accepted
2023-08-18 21:20:00
Documents
1
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2324159-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2324159-2_4seq1.xml 4 3213
  Complete submission text file 0001104659-23-093619.txt   4645
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MALLINCKRODT PHARMACEUTICALS 675 MCDONNELL BLVD. HAZELWOOD MO 63042
Business Address
Harrold Kassie (Reporting) CIK: 0001849332 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 231187128